Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs

Cantor Fitzgerald has initiated coverage on Innoviva, Inc. (NASDAQ:INVA), citing the company's unique business model centered around royalties and healthcare assets.The company receives royalties from

BenzingaJun 18 13:44 ET

ITeos And GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug And Dostarlimab In Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer; Primary Endpoints Of The Trial Are Progression...

ITeos And GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug And Dostarlimab In Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Can

BenzingaJun 17 09:07 ET

The $3bn Crisis Casting a Shadow Over Dame Emma Walmsley's GSK

Yahoo FinanceJun 16 08:00 ET

CDC 'Preparing for the Possibility' Bird Flu Could Spread More Easily

Seeking AlphaJun 14 10:59 ET

Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says

Moderna's (MRNA) newly approved respiratory syncytial virus vaccine may achieve stronger than expected US penetration despite entering a market with two seasoned competitors, Oppenheimer said in a Wed

MT NewswiresJun 12 15:37 ET

Express News | World Health Organization Chief: At This Time, Who Continues To Assess Risk To Public Health From H5n1 As Low

BenzingaJun 12 10:40 ET